SEC Form 4 · accession 0001104659-26-088370
Yarrow Bioscience, Inc. · YARW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tyler Zeronda
Director
Period of report
Jul 27, 2026
Accepted (ET)
Jul 29, 2026 · 9:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001566044
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $28.56 | Jul 27, 2026 | A | 185,798 | A | — | Jul 27, 2036 | Common Stock | 185,798 | 185,798 | D |
Explanation of responses
- F1This option represents a right to purchase 185,798 shares of the Issuer's common stock, one quarter of which will vest on July 27, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
Remarks
Exhibit 24 - Power of Attorney